Royal Bank of Canada’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21K | Buy |
1,755
+1,483
| +545% | +$12.3K | ﹤0.01% | 6316 |
|
|
2026
Q1 | $2K | Sell |
272
-1,505
| -85% | -$15.8K | ﹤0.01% | 6751 |
|
|
2025
Q4 | $26K | Sell |
1,777
-45,146
| -96% | -$563K | ﹤0.01% | 5898 |
|
|
2025
Q3 | $453K | Buy |
46,923
+40,101
| +588% | +$355K | ﹤0.01% | 4564 |
|
|
2025
Q2 | $56K | Buy |
6,822
+2,917
| +75% | +$24.4K | ﹤0.01% | 5879 |
|
|
2025
Q1 | $28K | Sell |
3,905
-2,812
| -42% | -$20.9K | ﹤0.01% | 5801 |
|
|
2024
Q4 | $52K | Buy |
6,717
+1,836
| +38% | +$17.2K | ﹤0.01% | 5677 |
|
|
2024
Q3 | $51K | Buy |
4,881
+277
| +6% | +$3.38K | ﹤0.01% | 5695 |
|
|
2024
Q2 | $54K | Buy |
4,604
+2,327
| +102% | +$36.2K | ﹤0.01% | 5614 |
|
|
2024
Q1 | $48K | Sell |
2,277
-11,374
| -83% | -$202K | ﹤0.01% | 5563 |
|
|
2023
Q4 | $244K | Buy |
13,651
+6,190
| +83% | +$109K | ﹤0.01% | 4931 |
|
|
2023
Q3 | $123K | Buy |
7,461
+2,242
| +43% | +$40.6K | ﹤0.01% | 5247 |
|
|
2023
Q2 | $105K | Buy |
5,219
+1,405
| +37% | +$27.1K | ﹤0.01% | 5302 |
|
|
2023
Q1 | $71K | Sell |
3,814
-2,682
| -41% | -$59.3K | ﹤0.01% | 5427 |
|
|
2022
Q4 | $149K | Buy |
6,496
+5,099
| +365% | +$115K | ﹤0.01% | 5147 |
|
|
2022
Q3 | $37K | Buy |
1,397
+915
| +190% | +$27.1K | ﹤0.01% | 5896 |
|
|
2022
Q2 | $12K | Sell |
482
-2,265
| -82% | -$56.6K | ﹤0.01% | 6320 |
|
|
2022
Q1 | $91K | Sell |
2,747
-5,153
| -65% | -$143K | ﹤0.01% | 5724 |
|
|
2021
Q4 | $259K | Buy |
7,900
+3,960
| +101% | +$135K | ﹤0.01% | 5080 |
|
|
2021
Q3 | $165K | Buy |
3,940
+737
| +23% | +$26.5K | ﹤0.01% | 5337 |
|
|
2021
Q2 | $125K | Buy |
3,203
+955
| +42% | +$34.2K | ﹤0.01% | 5458 |
|
|
2021
Q1 | $77K | Sell |
2,248
-7,212
| -76% | -$308K | ﹤0.01% | 5627 |
|
|
2020
Q4 | $429K | Buy |
9,460
+734
| +8% | +$25.6K | ﹤0.01% | 4272 |
|
|
2020
Q3 | $240K | Sell |
8,726
-826
| -9% | -$26.9K | ﹤0.01% | 4414 |
|
|
2020
Q2 | $352K | Sell |
9,552
-1,074
| -10% | -$40K | ﹤0.01% | 4050 |
|
|
2020
Q1 | $344K | Buy |
10,626
+4,751
| +81% | +$198K | ﹤0.01% | 3933 |
|
|
2019
Q4 | $241K | Buy |
5,875
+3,270
| +126% | +$129K | ﹤0.01% | 4510 |
|
|
2019
Q3 | $92K | Sell |
2,605
-1,305
| -33% | -$52.9K | ﹤0.01% | 4838 |
|
|
2019
Q2 | $201K | Buy |
3,910
+1,040
| +36% | +$51.9K | ﹤0.01% | 4479 |
|
|
2019
Q1 | $165K | Buy |
2,870
+1,656
| +136% | +$82K | ﹤0.01% | 4467 |
|
|
2018
Q4 | $51K | Sell |
1,214
-1,557
| -56% | -$91.3K | ﹤0.01% | 5096 |
|
|
2018
Q3 | $210K | Buy |
2,771
+1,625
| +142% | +$117K | ﹤0.01% | 4445 |
|
|
2018
Q2 | $82K | Buy |
1,146
+1,104
| +2,629% | +$52.7K | ﹤0.01% | 4915 |
|
|
2018
Q1 | $1K | Sell |
42
-1,596
| -97% | -$46.4K | ﹤0.01% | 6223 |
|
|
2017
Q4 | $54K | Sell |
1,638
-3,253
| -67% | -$98K | ﹤0.01% | 5140 |
|
|
2017
Q3 | $161K | Buy |
4,891
+3,081
| +170% | +$69.3K | ﹤0.01% | 4665 |
|
|
2017
Q2 | $36K | Buy |
1,810
+519
| +40% | +$10.1K | ﹤0.01% | 5278 |
|
|
2017
Q1 | $24K | Sell |
1,291
-748
| -37% | -$14.4K | ﹤0.01% | 5539 |
|
|
2016
Q4 | $38K | Buy |
2,039
+1,239
| +155% | +$23.7K | ﹤0.01% | 5418 |
|
|
2016
Q3 | $11K | Hold |
800
| – | – | ﹤0.01% | 5753 |
|
|
2016
Q2 | $6K | Sell |
800
-300
| -27% | -$3.33K | ﹤0.01% | 5898 |
|
|
2016
Q1 | $12K | Hold |
1,100
| – | – | ﹤0.01% | 5671 |
|
|
2015
Q4 | $18K | Buy |
1,100
+300
| +38% | +$5.95K | ﹤0.01% | 5752 |
|
|
2015
Q3 | $18K | Buy |
+800
| New | +$20.4K | ﹤0.01% | 5614 |
|
Other funds holding RGNX
RG
Royal Bank of Canada's RGNX Position: Q2 2026 in Review
Royal Bank of Canada increased its Regenxbio (RGNX) stake by 545% in Q2 2026, buying an estimated $12.3K and bringing the position to 1,755 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #6316.
Royal Bank of Canada first reported a position in RGNX in Q3 2015 and has held it in 44 quarters since. The position peaked at $453K in Q3 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Royal Bank of Canada held 1,755 shares of Regenxbio worth $21K as of Q2 2026.
- Royal Bank of Canada bought 1,483 Regenxbio shares in Q2 2026, an estimated $12.3K.
- Regenxbio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6316 holding.
- Royal Bank of Canada first reported a position in Regenxbio in Q3 2015 and has held it in 44 quarters since.
- Royal Bank of Canada's Regenxbio position peaked at $453K in Q3 2025.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.